TLX66 Meets Study Objectives in Patients with AL Amyloidosis
Go back to TLX66 Meets Study Objectives in Patients with AL Amyloidosis| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 12.15 +0.28 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.87 | 52 Week High | $2.18 | |||
| Open | $11.97 | 52 Week Low | $0.30 | |||
| Day High | $12.23 | P/E | N/A | |||
| Day Low | $11.97 | EPS | $-3.32 | |||
| Volume | 201,585 | |||||
